What is the Impact Factor of Antibiotics-Basel?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Antibiotics-Basel is 5.50, ranking in quartile Q1 of Web of Science (SCIE).

Is Antibiotics-Basel indexed in Web of Science or Scopus?

Yes, Antibiotics-Basel is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.276 (Q1) and an H-index of 124.

Who publishes Antibiotics-Basel and what is the Article Processing Charge (APC)?

Antibiotics-Basel is published by Multidisciplinary Digital Publishing Institute (MDPI). The estimated Article Processing Charge (APC) is approximately $3,315 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Antibiotics-Basel?

The official ISO-4 abbreviation of Antibiotics-Basel is "ANTIBIOTICS-BASEL". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #3,261Hybrid

Antibiotics-Basel

Abbreviation (ISO):ANTIBIOTICS-BASEL

•

Identifier (ISSN):2079-6382(Print)

•

Publisher:Multidisciplinary Digital Publishing Institute (MDPI)

Official Website Submission Portal Compare

Clarivate IF (2026)

5.5↑ +0.9

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Antibiotics-Basel

WoS Q1

Annual Impact Factor Metric

Current (2026):5.5

Scopus SJR & RankScopus Q1

1.276

#3,261

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

124

124 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate14%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

1,519articles/year

99.95% Gold OA•85.11% Original Research

Aims & Scope

Antibiotics (ISSN 2079-6382) is an open access, peer reviewed journal on all aspects of antibiotics. Antibiotics is a multi-disciplinary journal encompassing the general fields of biochemistry, chemistry, genetics, microbiology and pharmacology. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, there is no restriction on the length of papers.

Topics Covered (Recognized by AI)

Biology97%Chemistry91.4%Genetics89.1%Biochemistry86%Microbiology85.3%Medicine76.9%Antibiotics68.1%Geology67.3%Paleontology66.9%Bacteria64.2%Organic chemistry47.9%Internal medicine36.1%Antimicrobial35.2%Gene34.7%Antibiotic resistance31%Pathology28%Escherichia coli21.7%

Primary Research Areas

Pharmacology Toxicology and Pharmaceutics General Pharmacology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

INFECTIOUS DISEASES

Rank18/141

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank56/356

IndexSCIE

JCISCIE2026

INFECTIOUS DISEASES

Rank21/141

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank61/356

IndexSCIE

Category	Index	Rank	Quartile
INFECTIOUS DISEASES	JCRSCIE	18/141	Q1
PHARMACOLOGY & PHARMACY	JCRSCIE	56/356	Q1
INFECTIOUS DISEASES	JCISCIE	21/141	Q1
PHARMACOLOGY & PHARMACY	JCISCIE	61/356	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF5.5

Articles / Year888

Total Citations584

2025

IF4.6

Articles / Year1,298

Total Citations7,538

2024

IF4.3

Articles / Year1,220

Total Citations13,099

2023

IF4.8

Articles / Year1,715

Total Citations31,384

2022

IF5.222

Articles / Year1,873

Total Citations44,037

Year	Impact Factor	Articles / Year	Total Citations
2026	5.5	888	584
2025	4.6	1,298	7,538
2024	4.3	1,220	13,099
2023	4.8	1,715	31,384
2022	5.222	1,873	44,037
2021	4.639	1,582	46,442
2020	3.893	949	38,657
2019	—	291	11,959
2018	—	112	6,387
2017	—	42	2,277
2016	—	37	1,792
2015	—	67	1,960

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,261Scopus Q1SCImago Profile

Scopus Coverage:2010, 2012-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

1.276

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

5.83

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,315 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations29,079

3-Year Documents4,787

Citable Documents4,725

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)3

Citations in government and international policy documents

Female Author Rate50.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ1

Infectious DiseasesQ1

MicrobiologyQ1

Microbiology (medical)Q1

Pharmacology (medical)Q1

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 14%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区INFECTIOUS DISEASES

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Antibiotics-Basel (abbr: ANTIBIOTICS-BASEL, ISSN: 2079-6382) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Multidisciplinary Digital Publishing Institute (MDPI) in Switzerland. The periodical holds a Journal Impact Factor (JIF) of 5.50, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.276 (Q1), an H-index of 124.

The journal enforces rigorous peer evaluation with an annual output of approximately 1,519 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,315 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.